COO exercises options and sells 35,643 shares in Adaptive Biotechnologies (ADPT).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Adaptive Biotechnologies' President and COO, Julie Rubinstein, exercised options for 35,643 common shares at an exercise price of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context